Psilocybin study enrolls clinicians with COVID-linked blues

Mark Stone / University of Washington
Dr. Tim Dellit, left, comforts Dr. Thuan Ong after Ong was overcome with emotion upon receiving a COVID-19 vaccination.

Enrollment has begun in a small study of whether psilocybin-assisted psychotherapy can help alleviate symptoms of depression and anxiety that front-line clinicians developed during the COVID-19 pandemic.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.